Diese Website verwendet Cookies, um das Angebot nutzerfreundlicher und effektiver zu machen. Mit der Nutzung dieser Website stimmen Sie der Verwendung von Cookies zu.Weitere Informationen über die Verwendung von Cookies und die Möglichkeit der Verwendung von Cookies zu widersprechen, finden Sie hier.
WEGO HOLDING COMPANY LIMITED (“WEGO”) was established in March 1988, and the principal businesses of WEGO focus on medical devices and pharmaceuticals. In addition, WEGO develops some other business such as real estate, investment and so on. WEGO has 9 industry groups and more than 30 subsidiaries. WEGO Holding's subsidiary ---SHANDONG WEIGAO GROUP MEDICAL POLYMER CO., LIMITED is listed in Hong Kong.
The main products of WEGO are infusion sets, syringes, blood transfusion equipments, heart stents, intracardiac consumables，IV catheters special needles, blood purification equipments and consumables, orthopedic materials, operation room equipments and accessories, wound care products, minimally invasive instruments and equipments, ICU products and accessories, high-capacity injections and pharmaceuticals, renal products, biological diagnostic reagents, PVC &non-PVC materials and so on. WEGO produces more than 30 series, 400 categories and 60,000 specifications products, and now has become one of the most reliable suppliers of medical system solutions in the world. At the same time, WEGO energetically takes part in healthcare service and provides renal dialysis service.
WEGO insists on adjusting industry structure by technology innovation and improving the ability of independent innovation, and has been qualified as the “Industrialization Base of the National High-tech R&D Program(863 Program)” and the “Key High & New Technology Enterprise of the China Torch Program”. WEGO also has built up a state-level enterprise technology center, a national engineering laboratory of medical implant devices, a national key laboratory, a academician working center, a post-doctoral working center, a Taishan scholar working center, and also cooperates with scientific research institutions, universities and hospitals setting up 20 R&D centers or joint laboratories. Today WEGO has 50 products with patent for invention, more than 340 products with independent intellectual property, and more than 80% of total products being the high-tech and high added-value products. WEGO insists on scientific management, and implements various of information system such as ERP, SRM, and BPM. In this way the decision-making level and management efficiency and quality are promoted. In addition, under the branding strategy, the WEGO products are sold in more than 30 provinces and municipalities, which covered 81.3% of tertiary hospitals and 77.2% of blood banks in China, and also exported to over 70 countries and areas.
WEGO has always been adhering the mission of“Your health, We care” and the core values of ”Conscience, Integrity, Loyalty”. Such spirit makes WEGO insist on undertaking social responsibilities, and promoting the construction of harmonious society. In recent years, WEGO carries out WEGO Light Action, WEGO Loving Care Project and actively subsidizes schools, villages, workers and students with poverty. WEGO is trying to become an international company, trying to achieve the vision of “To be one of the global elites; Pioneer in Asia; Most respectable medical device and medication enterprise”, and trying to make contributions to China's medical and healthcare industry.